
Lenvima Capsule - Receptor Tyrosine Kinase Inhibitor For Advanced Rcc Treatment | Effective Combination With Everolimus
Price:
Get Latest Price
In Stock
Product Overview
Key Features
Lenvima (lenvatinib) is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4).
Lenvima is specifically indicated for use in combination with everolimus for the treatment of patients with advanced RCC following one prior anti-angiogenic therapy.
Company Details
Business Type
Exporter, Distributor
Employee Count
100
Establishment
1987
Working Days
Sunday To Sunday
Payment Mode
Western Union
Related Products
Explore Related Categories
More Product From This seller
Seller Details
Palghar, Maharashtra
Accepts only Foreign inquiries
Jiten Aggarwal
Address
Address: H.301 Maxheal house, tarapur industrial area, Dist. Palghar, Maharashtra, 401506, India
pharmaceutical capsules in Palghar
Report incorrect details